Sveriges mest populära poddar

Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)

8 min•12 juli 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.

See omnystudio.com/listener for privacy information.

Fler avsnitt

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

26 sep.48 min

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

25 sep.18 min

Meta Introduces Palm-Sized Device to Use Muse AI

24 sep.19 min

Disney+ Price to Jump 13% to $21.49 Per Month

23 sep.22 min

Meta’s New Muse AI App Makes Shopping Easier

22 sep.17 min

Paramount to Settle Lawsuits Against WBD Deal

21 sep.19 min

The Bank of Mom & Dad; College Sports Going Pro & The Return of the Suit

19 sep.44 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.